Researchers
Bila, Jelena
| Issue Date | Title | Author(s) | Type | М-cat. |
|---|---|---|---|---|
| 2022 | Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo Study | Dimopoulos, Meletios A; Terpos, Evangelos; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Baldini, Luca; Symeonidis, Argiris; Bila, Jelena S   ;
Oriol, Albert; Mateos, Maria-Victoria; Einsele, Hermann; Orfanidis, Ioannis; Kampfenkel, Tobias; Liu, Weiping; Kosh, Michele; NamPhuong, Tran; Carson, Robin; Sonneveld, Pieter;
| Conference Paper | Mp. category will be shown later |
| 2022 | MajesTEC-4 (EMN30): A Phase 3 Trial of Teclistamab plus Lenalidomide Versus Lenalidomide Alone As Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma | Zamagni, Elena; ...; Bila, Jelena S ; ...; (broj, koautora 22) | Conference Paper | Mp. category will be shown later |
| 2021 | Pomalidomide and Dexamethasone with or without Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Updated Analysis of the Phase 3 Apollo Study | Sonneveld, Pieter; ...; Bila, Jelena S ; ...; (broj, koautora 21) | Conference Paper | Mp. category will be shown later |
| 2021 | Prognostic impact of response-adjusted ISS score in Multiple Myeloma | Mitrovic, Marko; Bukumiric, Zoran M ; Sretenovic, Aleksandra M; Miketic, Ivana; Bila, Jelena S | Conference Paper | Mp. category will be shown later |
| 2021 | Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study | Jagannath, Sundar; ...; Bila, Jelena S ; ...; (broj, koautora 45) | Conference Paper | Mp. category will be shown later |
| 2021 | The implication and consequence of CD34+cell/subset quantity/ratio on the clinical outcome of hematologic malignancies treated by autologous stem cell transplants | Todorovic, Milena R; Pavlovic, Mirjana A; Bila, Jelena S ; Balint, Bela J | Conference Paper | Mp. category will be shown later |
| 2021 | Ultra-high-risk prognostic significance of double and triple hit myeloma | Bila, Jelena S ; Mitrovic, Marko; Bukumiric, Zoran M ; Jovanovic, Jelica V; Dencic-Fekete, Marija; Sretenovic, Aleksandra M; Jelicic, Jelena J ; Peric, Teodora; Mihaljevic, Biljana S ; Antic, Darko A | Conference Paper | Mp. category will be shown later |
| 2021 | Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO. | Terpos, Evangelos; ...; Bila, Jelena S ; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
| 2021 | APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM) | Einsele, H; ...; Bila, Jelena S ; ...; (broj, koautora 23) | Conference Paper | Mp. category will be shown later |
| 2020 | Induction of remission in a heavily pretreated patient with diffuse large B-cell lymphoma (DLBCL) who relapsed after the therapy with CAR-T-cells - case report | Kuepper, K; Georgi, T; Bach, E; Leiblein, S; Sretenovic, Aleksandra M; Hoffmann, S; Tumewu, T; Bila, Jelena S ; Franke, G-N; Platzbecker, U;
Vucinic, Vladan;
| Conference Paper | Mp. category will be shown later |
| 2018 | A Real World Multicenter Retrospective Analysis of Extramedullary Disease from Balkan Myeloma Study Group and Barcelona University: Comparison of Paraosseous and Soft Tissue Plasmacytomas | Beksac, Meral; Kanellias, Nicholas; Rosinol, Laura; Seval, Guldane Cengiz; Ozet, Gulsum; Goranova-Marinova, Vesselina; Coriu, Daniel; Bila, Jelena S ; Ozsan, Hayri; Balic, LI;
Ivanaj, Arben; Kastritis, Efstathios; Blade, Joan; Dimopoulos, Meletios Athanasios;
| Conference Paper | Mp. category will be shown later |
| 2018 | Fish in Multiple Myeloma: Benefits and Obstacles | Dencic-Fekete, Marija; Bila, Jelena S ; Jelicic, Jelena J ; Sretenovic, Aleksandra M; Jovanovic, Jelica V; Perunicic-Jovanovic, Maja D; Jakovic, Ljubomir R ; Bogdanovic, Andrija D ; Mihaljevic, Biljana S | Conference Paper | Mp. category will be shown later |
| 2018 | Removable Dinoprostone Vaginal Delivery System: Cost-Consequences Model for Central and Eastern Europe Countries | Pacocha, K; ...; Bila, Jelena S ; ...; (broj, koautora 16) | Conference Paper | Mp. category will be shown later |
| 2017 | Richter Syndrome: Serbian Lymphoma Group Experience | Vukovic, Vojin M ; Antic, Darko A ; Milic, Natasa M; Todorovic-Balint, Milena R; Bila, Jelena S ; Andjelic, Bosko M; Djurasinovic, Vladislava T; Sretenovic, Aleksandra M; Smiljanic, Mihailo; Jelicic, Jelena J ;
Perunicic-Jovanovic, Maja D; Kraguljac-Kurtovic, Nada
; Djurdjevic, Predrag M ; Cvetkovic, Zorica P; Zivanovic, Aneta S; Mihaljevic, Biljana S ; | Conference Paper | Mp. category will be shown later |
| 2017 | Advanced Hodgkin Lymphoma Patients Without Large Tumor Mass - a New Prognostic Score Identifies Patients with Favorable Outcome | Andjelic, Bosko M; Antic, Darko A ; Jakovic, Ljubomir R ; Todorovic, Marija R; Bila, Jelena S ; Djurasinovic, Vladislava T; Vukovic, Vojin M ; Sretenovic, Aleksandra M; Jelicic, Jelena J ; Smiljanic, Mihailo;
Mihaljevic, Biljana S
; | Conference Paper | Mp. category will be shown later |
| 2017 | Overexpression of gene for human concentrative nucleoside transporter 3 is a predictor of resistance to fludarabin-based chemotherapy in patients with chronic lymphocytic leukemia | Vuković, V.; Antić, Darko ; Karan-Đurašević, Teodora ; Milić, N.; Todorovic-Balint, M.; Bila, J. ; Anđelić, Boško; Đurašinović, Vladislava; Sretenović, A.; Smiljanić, M.;
Jelicić, J.
; Denčić-Fekete, Marija; Perunicić-Jovanović, M.; Kraguljac-Kurtović, N. ; Pavlović, Sonja ; Mihaljević, B. ; | Conference Paper | Mp. category will be shown later |
| 2017 | CD34+cell dose is an independent prognostic factor in patients with Hodgkin lymphoma and multiple myeloma who underwent autologous stem cell transplantation | Todorovic-Balint, Milena R; Jelicic, Jelena J ; Bila, Jelena S ; Vujic, Dragana S; Balint, Bela J ; Kraguljac-Kurtovic, Nada ; Sefer, Dijana; Serbic, Olivera; Lazic, Emilija; Antic, Darko A ;
Andjelic, Bosko M; Smiljanic, Mihailo; Sretenovic, Aleksandra M; Mihaljevic, Biljana S
; | Conference Paper | Mp. category will be shown later |
| 2017 | Comparative Analysis of Predictive Models for Thromboembolic Events in Lymphoma Patients (✓) | Antić, Darko A. ; Milić, Nataša M. ; Nikolovski, Srđan S. ; Todorović, Marija R.; Bila, Jelena S. ; Đurđević, Predrag M. ; Anđelić, Boško M.; Đurašinović, Vladislava T.; Sretenović, Aleksandra M.; Smiljanić, Mihailo;
Vuković, Vojin M.
; Jeličić, Jelena J. ; Mihaljević, Biljana S. ; | Conference Paper | Mp. category will be shown later |
| 2017 | Comparative analysis of international prognostic index for chronic lymphocytic leukemia, progression-risk score and md anderson cancer center 2011 score: real world data from a single institution | Vuković, V.; Antić, Darko ; Karan-Đurašević, Teodora ; Milić, N.; Todorovic-Balint, M.; Bila, J. ; Anđelić, Boško; Đurašinović, Vladislava; Sretenović, A.; Smiljanić, M.;
Jelicić, J.
; Denčić-Fekete, Marija; Perunicić-Jovanović, M.; Kraguljac-Kurtović, N. ; Pavlović, Sonja ; Mihaljević, B. ; | Conference Paper | Mp. category will be shown later |
| 2017 | Low Albumin Level Correlates with Poorer Survival of Patients with Diffuse Large B Cell Lymphoma: Serbian Lymphoma Group Experience (✓) | Jelicic, Jelena J ; Antic, Darko A ; Todorovic-Balint, Milena R; Andjelic, Bosko M; Markovic, Olivera B; Petkovic, Ivan Z ; Nikolic, Vesna; Bila, Jelena S ; Djurasinovic, Vladislava T; Sretenovic, Aleksandra M;
Vukovic, Vojin M
; Smiljanic, Mihailo; Mihaljevic, Biljana S ; | Conference Paper | Mp. category will be shown later |